RECRUITING

Study of Healthy Cohort for Early Detection of Cancer

Conditions

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

Cancer produces a significant burden on society with a majority diagnosed at late stages when the chance of cure is low. Early diagnosis improves patient outcomes. Data consisting of lifestyle factors, medications, physical activity, years before conventional cancer diagnosis is also worthwhile for to determine early detection. This is only achievable with longitudinal tracking of a large number of healthy individuals and identifying those who do develop cancer over time.

Official Title

Study of Healthy Cohort for Early Detection of Cancer

Quick Facts

Study Start:2023-02-01
Study Completion:2043-02-28
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT05193305

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:Not specified
Standard Ages:ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. * All adults 18 years of age of older undergoing upper or lower endoscopy for routine medical care.
  1. * Persons with current malignancy
  2. * Persons with history of malignancy and treatment within last 5 years of enrollment, excluding non-melanoma skin cancer or cervical in-situ.
  3. * Persons who are unable or unwilling to provide repeat blood samples and complete follow-up questionnaires
  4. * Persons who lack the capacity to provide consent
  5. * Persons who do not speak English
  6. * Persons who are visually or hearing impaired.

Contacts and Locations

Study Contact

Elham Afghani
CONTACT
410-955-5000
eafghan1@jhmi.edu

Principal Investigator

Elham Afghani
PRINCIPAL_INVESTIGATOR
Johns Hopkins University

Study Locations (Sites)

Johns Hopkins Hospital
Baltimore, Maryland, 21205
United States

Collaborators and Investigators

Sponsor: Johns Hopkins University

  • Elham Afghani, PRINCIPAL_INVESTIGATOR, Johns Hopkins University

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2023-02-01
Study Completion Date2043-02-28

Study Record Updates

Study Start Date2023-02-01
Study Completion Date2043-02-28

Terms related to this study

Additional Relevant MeSH Terms

  • Healthy